古塞奇尤单抗治疗伴关节受累的斑块状银屑病1例

doi:10.35541/cjd.20201162

Chinese Journal of Dermatology ›› 2023, Vol. 56 ›› Issue (4): 347-348.doi: 10.35541/cjd.20201162

• Case Reports • Previous Articles Next Articles

Guselkumab for the treatment of a case of plaque psoriasis with joint involvement

Xue Lu, Wang Huiping, Li Yan

Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, China

Received:2020-12-03 Revised:2021-06-27 Online:2023-04-15 Published:2023-03-31
Contact: Li Yan E-mail:13702115619@163.com

Abstract

Xue Lu, Wang Huiping, Li Yan. Guselkumab for the treatment of a case of plaque psoriasis with joint involvement[J]. Chinese Journal of Dermatology, 2023, 56(4): 347-348.doi:10.35541/cjd.20201162

［1］	《中国关节病型银屑病诊疗共识（2020）》编写委员会专家组. 中国关节病型银屑病诊疗共识（2020）［J］. 中华皮肤科杂志, 2020,53（8）:585⁃595. doi: 10.35541/cjd.20200369.
［2］	Mease PJ, Rahman P, Gottlieb AB, et al. Guselkumab in biologic⁃naive patients with active psoriatic arthritis （DISCOVER⁃2）: a double⁃blind, randomised, placebo⁃controlled phase 3 trial［J］. Lancet, 2020,395（10230）:1126⁃1136. doi: 10.1016/S0140⁃6736（20）30263⁃4.
［3］	Deodhar A, Helliwell PS, Boehncke WH, et al. Guselkumab in patients with active psoriatic arthritis who were biologic⁃naive or had previously received TNFα inhibitor treatment （DISCOVER⁃1）: a double⁃blind, randomised, placebo⁃controlled phase 3 trial［J］. Lancet, 2020,395（10230）:1115⁃1125. doi: 10.1016/S0140⁃6736（20）30265⁃8.

Guselkumab for the treatment of a case of plaque psoriasis with joint involvement

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［3］

Related Articles 0

Metrics

Comments

Recommended 10